SUMMARY
The precise cellular mechanisms by which opioids modulate pain transmission in the central nervous system are unknown. Occupation of presynaptic opioid receptors reduces evoked neurotransmitter release, and this has been demonstrated in a variety of tissue preparations and for different neurotransmitters [1] . However, there is only limited evidence that opioids modulate neurotransmitter uptake. For instance, morphine, methadone, codeine and thebaine reduced [ 3 H]noradrenaline uptake in rabbit brain synaptosomes [2] . Similarly, methadone and morphine reduced [ 3 H]5-hydroxytryptamine uptake in rat brain synaptosomes, but only methadone reduced [ 3 H]noradrenaline uptake [3] . In addition, the importance of the modulation of neuronal amine uptake in the production of analgesia remains to be established.
In this study we have used two noradrenergic cell lines-a human neuroblastoma, SH-SY5Y [4, 5] and a rat phaeochromocytoma, PC 12 [6] -to examine the effect of fentanyl on [ 3 H]noradrenaline uptake, and to compare this with the effects of morphine and imipramine. Isolated clonal cells are homogeneous and this is a useful attribute in the study of neurotransmitter modulation. Furthermore, they are not associated with problems such as diffusion limitations and unwanted cellular interactions that may occur with brain slice preparations. These cells are relatively easy to culture and are capable of uptake and release of noradrenaline [7, 8] . Moreover, SH-SY5Y cells express u and 8 opioid receptors [9] , but the exact receptor profile of PC 12 remains unknown.
A preliminary account of this work has been published as an abstract [10] . 
MATERIALS AND METHODS

Cell
Modulation of [ 3 H]noradrenaline uptake
The effect of fentanyl on [ All experiments except those to determine the maximum uptake of [ 
Statistical analysis
Data are expressed as mean (SEM) and were analysed using ANOVA and Student's paired or unpaired t test as appropriate and considered significant when P < 0.05. Curve fitting for the estimation of half-maximum uptake and IC 50 values was performed by non-linear regression using "Graphpad".
RESULTS
Both cell lines were capable of the uptake of [ 3 H]NA, with a maximum uptake of approximately 26 % and 7.5 % for SH-SY5Y cells and PC12 cells, respectively ( fig. 1 ). Half-maximum uptake occurred at 5.7 (0.2) min (w = 5) and 9.3 (1.5) min (w = 5) for SH-SY5Y cells and PC 12 cells, respectively (unpaired t test, P > 0.05). Maximum uptake occurred within 60 min and therefore all remaining experiments were performed after a 60-min incubation period. (fig. 2) . The inhibition by fentanyl was dose-dependent (ANOVA, P < 0.05) and at the maximum concentration used (100 umol litre" 1 ), 85-95% inhibition was observed. Assuming a maximum inhibitory effect of 100%, the IC 50 values for fentanyl were 5.37 nmol litre" 1 and 2.09 nmol litre" 1 in SH-SY5Y and PC12 cells, respectively.
In order to assess the specificity and mechanism of fentanyl inhibition, we examined the effects of morphine, naloxone and the uptake-1 inhibitor, imipramine ( fig. 3 ). Imipramine 1 umol litre" 1 produced a significant depression of uptake (65-70 %) in both cell lines, compared with 26-38 % inhibition by the same concentration of fentanyl. Morphine 1 umol litre" 1 and naloxone 1 umol litre" 1 alone had no significant effect. More importantly, naloxone did not antagonize fentanyl-mediated inhibition of noradrenaline uptake. Morphine and naloxone had no effect. Naloxone did not antagonize fentanyl inhibition of uptake.
DISCUSSION
Undifferentiated SH-SY5Y and PC 12 cells are both capable of the uptake of [ 3 H]noradrenaline, with a maximum uptake of approximately 26.0% and 7.5 %, respectively. In addition, we have shown a clear, dose-dependent inhibition of noradrenaline uptake by fentanyl in both noradrenergic neuronal cell lines. However, this inhibition was not antagonized by naloxone and is therefore not mediated via the opioid receptor. As would be expected, imipramine 1 umol litre" 1 produced 65-70 % inhibition of uptake, indicating the presence of the uptake-1 system in these cells.
The ability of SH-SY5Y cells to take up [ 3 H]NA is in agreement with the findings of Scott and colleagues, who have shown a maximum uptake of 18% in differentiated SH-SY5Y cells [11] , but no studies were made on the modulation of uptake. A maximum uptake of approximately 7.5% in PC 12 cells contrasts with the findings of Green and Rein, who achieved a maximum uptake of 17-36% [7] , although maximum uptake depends on seeding density. They also examined the K m and Fmax of [ 3 H]NA uptake in PC 12 cells and demonstrated that cell differentiation does not alter the kinetics of the uptake system itself [6] .
The inactivity of morphine on [ [13] . The effect of morphine was not antagonized by naloxone, also indicating a mechanism of action independent of the opioid receptor.
Catecholamine uptake by neurones occurs in two, distinct processes [14] . The first system transports the amine from the synaptic cleft across the cell membrane and into the cytoplasm, requires a sodium-potassium-activated ATPase and is blocked by imipramine. This system contributes to the inactivation of the synaptic neurotransmitter effect. The second system transports the cytoplasmic amine into the storage vesicle, requires a magnesiumactivated ATPase and is inhibited by reserpine. The second system is responsible for the maintenance of transmitter stores. The mechanism of fentanyl inhibition of [ 3 H]NA uptake is unknown, but may involve direct interaction of the opioid with the cell membrane uptake system, similar to that of imipramine. Considerable structural variability exists amongst the tricyclic and atypical antidepressant drugs, all of which block amine uptake [15] . The problem is further complicated by the possibility that two membrane [ 3 H]NA uptake systems may exist [16] . Although there is no evidence that fentanyl (unlike reserpine) depletes noradrenaline stores, interference by fentanyl in vesicular uptake, although unlikely, cannot be excluded and further work is required to determine the exact site of fentanyl inhibition.
One question that remains is whether or not inhibition of noradrenaline uptake is of any clinical importance in the production of analgesia. Whilst we have shown that fentanyl produces a significant effect on [ 1 [18] -a concentration 10-fold smaller than that at which we have demonstrated an effect. The serum concentration of fentanyl that produces analgesia is 1-3 ng ml" 1 (approximately 3-10 nmol litre" 1 ) [19] . Large concentrations of opioid agonists and antagonists have been shown to inhibit amine uptake in synaptosomes [2, 3, 12, 20] , but there appears to be no correlation between the ability of these drugs to block amine uptake and their analgesic efficacy. Indeed, in one study naloxone and morphine inhibited noradrenaline uptake in rabbit brain synaptosomes in similar concentrations, suggesting that the inhibition of noradrenaline uptake by opioids does not contribute significantly to the production of analgesia [2] . This contrasts with in vivo and in vitro evidence using tramadol hydrochloride, a synthetic opioid with an analgesic potency comparable to that of codeine [21] . This drug binds with some selectivity for u receptors (/<C, = 2.10 umol litre" [22, 23] . Unlike the commonly used opioids, tramadol in clinical use is not associated with significant side effects such as respiratory depression and it appears that it produces analgesia by both an opioid (u receptor) and a non-opioid (inhibition of amine uptake) mechanism.
In conclusion, we have demonstrated a clear inhibition of noradrenaline uptake by fentanyl, although a significant effect occurred only with serum concentrations of fentanyl greater than those that produce analgesia. However, it may be of some importance in those patients receiving large doses, for instance, during cardiac anaesthesia. Whilst the role of amine uptake inhibition in the production of analgesia is unclear, it may be important for some analgesic drugs.
